United States · Platforms & data · CNBC

Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand

Published by CNBC · United States 4 h ago

Read the full article on CNBC Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

The Motley Fool

Where Will VYM Be in 2036? Here’s What the 2.4% Yield Is Hiding.

NatWest Q3 Earnings Preview

Ormat Technologies (NYSE:ORA) Stock Picked Up by Analysts at Morgan Stanley

Earnings call transcript: Fiverr beats Q3 2026 estimates and lifts guidance

Best Energy Stocks

Stock Market Today (Oct. 29, 2026): Nasdaq futures fall on Alphabet earnings miss